Frauke Muecksch
banner
fraukemuecksch.bsky.social
Frauke Muecksch
@fraukemuecksch.bsky.social
Group Leader @ Heidelberg University's Center for Integrative Infectious Disease Research (CIID), former Postdoc @RockefellerUniversity
Interested in all things Virology!
HIV Infection | HIV Latency | virus-host interactions | SARS-CoV-2 antibody response
We are looking to recruit a Ph.D. student to start in Q1 2026 for an exciting new project that is part of the newly funded SynthImmune Cluster of Excellence. Are you interested in the intersection of virology and immunology? Please see the attached info and apply at application.synthimmune.de.
November 10, 2025 at 3:44 PM
Feeling deeply honored to receive this year's Aventis Life Science Bridge Award. Grateful to the Aventis Foundation for their support, and to my colleagues, mentors, collaborators, and my amazing research team who make this work possible. Excited to keep pushing our HIV research forward together.
This year's “Life Sciences Bridge Award ” goes to Dr. Judith Feucht, Dr. Frauke Mücksch and Dr. Varun Venkataramani. Congratulations! Read more: www.aventis-foundation.org and bridge.aventis-foundation.org
September 30, 2025 at 8:15 AM
Reposted by Frauke Muecksch
Die Abteilung Virologie am Zentrum für Infektiologie lädt gemeinsam mit der Aidshilfe Heidelberg am 1. Juli 2025 um 17 Uhr in die Heidelberger Akademie der Wissenschaften am Karlsplatz zu einer interaktiven Veranstaltung ein.
June 18, 2025 at 2:24 PM
Reposted by Frauke Muecksch
Applications are open for new Schaller Research Group Leader Positions in the field of Infectious Diseases at Heidelberg University. These generously funded positions of 5+2 years are a great opportunity for young virologists!

Find out more here:

www.klinikum.uni-heidelberg.de/fileadmin/in...
March 5, 2025 at 11:26 AM
Reposted by Frauke Muecksch
🚨 One week left to apply! 🚨
Don’t miss the chance to join the Gaebler & Ibrahim Labs for a cutting-edge postdoc position at the intersection of viral immunology, virology & gene regulation.

👉Apply here charite.hrpuls.de/de/job-offer...
November 18, 2024 at 9:18 AM
Received some nice news today - humbled to be included in the #Clarivate #HighlyCited2024 list! Very grateful to the incredible scientists who contributed to this. To all past & present colleagues, collaborators and mentors!
clarivate.com/news/clariva...
full list 👉 clarivate.com/highly-cited...
Clarivate Reveals Highly Cited Researchers 2024 List | Clarivate
Prioritizing research integrity with enhanced filters to address publication and citation manipulation
clarivate.com
November 19, 2024 at 4:28 PM
It was great fun to participate in yesterday’s panel discussion of the DZIF/HOPE workshop at #AIDS2024 - Bridging Communities: Enhancing Engagement through Language in HIV Research.
@DZIF_ @HOPEforHIVCure
January 31, 2025 at 3:01 PM
The next Berlin patient. Second #HIVCure @ChariteBerlin. @c_gaebler live on stage at @AIDS_conference presenting this remarkable case in Munich! @iasociety
January 31, 2025 at 3:01 PM
"One person dies of AIDS every minute. That is something that must change." - German Chancellor @OlafScholz at the #AIDS2024 opening ceremony in Munich. I could not agree more and I am looking forward to the next days hearing about science and interacting with the community.
January 31, 2025 at 3:01 PM
Wir freuen uns auf viele interessierte Besucher im @CiidHeidelberg anlässlich unserer Veranstaltung zum #WorldAIDSDay2023. @DZIF_ @uniklinik_hd
January 31, 2025 at 3:01 PM
Had such a good time the last 4 days at #IAS2023! My first time serving as a Rapporteur, so this was pretty intense 😄 Leaving with many good memories! Pictured is Lish @ndhlovulab presenting our team’s basic science highlights in the Rapporteur session!
January 31, 2025 at 3:01 PM
On my way back from a fantastic #cshlretro meeting @cshlmeetings! Had such a good time listening to great talks, having interesting discussions at posters and chatting with old and new friends!
January 31, 2025 at 3:02 PM
I am beyond excited to announce that I will be starting as a Chica and Heinz Schaller research group leader at the @CiidHeidelberg very soon - in July 2022 to be exact! I am thrilled to join the amazing infectious disease community in Heidelberg and can’t wait to get to work!
January 31, 2025 at 3:02 PM
Our most recent work on how mRNA booster vaccination modulates B cell responses to SARS-CoV-2 and its variants is now out in @Nature! A big thank you to the entire team behind this work, especially to @VinciZijun, Alice Cho & @c_gaebler. You are the best! http://disq.us/t/4718b09
Increased memory B cell potency and breadth after a SARS-...
A third dose of an mRNA vaccine against SARS-CoV-2 result...
disq.us
January 31, 2025 at 3:02 PM
1/ Our new work on antibody immunity following SARS-CoV-2 mRNA booster vaccination provides insight into why a 3rd dose of a vaccine that was not designed to protect against variants is so effective at preventing severe disease after Omicron-infection....
January 31, 2025 at 3:02 PM
Now out in peer-reviewed form: Plasma Neutralization of the SARS-CoV-2 Omicron Variant | @NEJM https://www.nejm.org/doi/full/10.1056/NEJMc2119641#.Yc8HrDYG4X8.twitter Thank you to everyone involved, especially Fabian, Yiska, Eva, @_JustinDaSilva, @PaulBieniasz, @theodora_nyc,...
January 31, 2025 at 3:02 PM
This is not about COVID for a change ;) I am excited to share my first HIV-1 paper in @PaulBieniasz’s lab! In collaboration with @CharlesBNader and @jinweizhang we show the HIV-1 matrix-tRNA complex structure and it’s implications for Gag localization http://tinyurl.com/4n6uarx5
ScienceDirect
tinyurl.com
January 31, 2025 at 3:07 PM
Very happy that one of our recent studies is now out in Immunity: antibody evolution leads to higher affinity antibodies with increased potency and breadth that can neutralize other sarbecoviruses and limit the options for viral escape....
January 31, 2025 at 3:07 PM
Good news: our most recent data suggest that immunity in convalescent individuals will be very long lasting and that convalescent individuals receiving mRNA vaccines produce antibodies and memory B cells that should be protective against circulating VOCs ...
January 31, 2025 at 3:07 PM
Our new work showing detailed analysis of the evolution of multiple independent SARS-CoV-2 antibody lineages is now out as a preprint! https://www.biorxiv.org/content/10.1101/2021.03.07.434227v1
January 31, 2025 at 3:12 PM
Our recent preprint about mRNA induced antibody responses is now out in Nature http://disq.us/t/3usekk0
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circul...
The Moderna (mRNA-1273) and Pfizer–BioNTech (BNT162b2) va...
disq.us
January 31, 2025 at 3:12 PM
Our study on longitudinal analysis of serology and neutralizing antibody levels in COVID19 convalescents is finally out in JID! Great collaboration between @SaraJenks2, Helen Wise & colleagues at the NHS Scottland and @PaulBieniasz and @theodora_nyc labs....
January 31, 2025 at 3:12 PM
This is very cool! Congratulations @VietLoanDaoThi. A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples https://stm.sciencemag.org/content/12/556/eabc7075
January 31, 2025 at 3:12 PM